Diagnostic Approach to Small Animal Bleeding Disorders

Topics in Companion Animal Medicine

Volumn 27, Issue 2, 2012, Pages 73-80

  Herring, Jennifer ^a   McMichael, Maureen ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cat; Coagulation; Dog; Fibrinolysis; Hemorrhage; Primary hemostasis; Secondary hemostasis

Indexed keywords

ANIMAL; ANIMAL DISEASE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD SAMPLING; CAT; CAT DISEASE; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; HOMEOSTASIS; METHODOLOGY; PHYSICAL EXAMINATION; PHYSIOLOGY; REVIEW;

ANIMALS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD SPECIMEN COLLECTION; CAT DISEASES; CATS; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; HOMEOSTASIS; PHYSICAL EXAMINATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 84866980426     PISSN: 19389736     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tcam.2012.07.004     Document Type: Review

References (79)

1. Key N.S. Diagnostic approaches to bleeding disorders. Hematology 2005, 10(suppl 1):29-32.
2. Girolami A., Luzzatto G., Varvarikis C., Pellati D., Sartori R., Girolami B. Main clinical manifestations of a bleeding diathesis: an often disregarded aspect of medical and surgical history taking. Haemophilia 2005, 11:193-202.
3. Girolami A., De Marco L., Dal Bo Zanon R., Patrassi G., Cappellato M.G. Rarer quantitative and qualitative abnormalities of coagulation. Clin Haematol 1985, 14:385-411.
4. Taylor R.E., Blatt P.M. Clinical evaluation of the patient with bruising and bleeding. J Am Acad Dermatol 1981, 4:348-368.
5. O'Marra S.K., Delaforcade A.M., Shaw S.P. Treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia. J Am Vet Med Assoc 2011, 238:346-352.
6. Callan M.B., Griot-Wenk M.E., Hackner S.G., Giger U. Persistent thrombopathy causing bleeding in 2 domestic shorthaired cats. J Vet Intern Med 2000, 14:217-220.
7. Burns E.R., Yoshikawa N. Hemolysis in serum samples drawn by emergency department personnel versus laboratory phlebotomists. Lab Med 2002, 33:377-380.
8. Sharp M.K., Mohammad S.F. Scaling of hemolysis in needles and catheters. Ann Biomed Eng 1998, 26:788-797.
9. Lippi G., Salvagno G.L., Montagnana M., Brocco G., Cesare Guidi G. Influence of the needle bore size used for collecting venous blood samples on routine clinical chemistry testing. Clin Chem Lab Med 2006, 44:1009-1014.
10. Bowen R.A., Hortin G.L., Csako G., Otañez O.H., Remaley A.T. Impact of blood collection devices on clinical chemistry assays. Clin Biochem 2010, 43:4-25.
11. Grant M.S. The effect of blood drawing techniques and equipment on the hemolysis of ED laboratory blood samples. J Emerg Nurs 2003, 29:116-121.
12. Ashavaid T.F., Dandekar S.P., Keny B., et al. Influence of blood specimen collection method on various preanalytical sample quality indicators in EDTA blood collected for cell counting. Indian J Clin Biochem 2008, 24:356-360.
13. Maeckelbergh V.A., Acierno M.J. Comparison of prothrombin time, activated partial thromboplastin time, and fibrinogen concentration in blood samples collected via an intravenous catheter versus direct venipuncture in dogs. Am J Vet Res 2008, 69:868-873.
14. Parenmark A., Landberg E. To mix or not to mix venous blood samples collected in vacuum tubes?. Clin Chem Lab Med 2011, 49(12):2061-2063.
15. Collection, transport and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline-fifth edition 2008, CLSI, Clinical and Laboratory Standards Institute, Wayne, PA, CLSI document H21-A5.
16. Millis D.L., Hawkins E., Jager M., Boyle C.R. Comparison of coagulation test results for blood samples obtained by means of direct venipuncture and through a jugular vein catheter in clinically normal dogs. J Am Vet Med Assoc 1995, 207:1311-1314.
17. Palsgaard-Van Lue A., Jensen A.L., Strom H., Strøm H., Kristensen A.T. Comparative analysis of haematological, haemostatic, and inflammatory parameters in canine venous and arterial blood samples. Vet J 2007, 173:664-668.
18. Bauer N.B., Er E., Moritz A. Influence of blood collection technique on platelet function and coagulation variables in dogs. Am J Vet Res 2011, 72:64-72.
19. Stokol T., Erb H.N. A comparison of platelet parameters in EDTA- and citrate-anticoagulated blood in dogs. Vet Clin Pathol 2007, 36:148-154.
20. Cerón J.J., Carli E., Tasca S., Martinez-Subiela S., Caldin M. Evaluation of EDTA hematology tubes for collection of blood samples for tests of secondary hemostasis in dogs. Am J Vet Res 2008, 69:1141-1147.
21. Crist R.A., Gibbs K., Rodgers G.M., Smock K.J. Effects of EDTA on routine and specialized coagulation testing and an easy method to distinguish EDTA-treated from citrated plasma samples. Lab Hematol 2009, 15:45-48.
22. Furlanello T., Caldin M., Stocco A., et al. Stability of stored canine plasma for hemostasis testing. Vet Clin Pathol 2006, 35:204-207.
23. Rizzo F., Papasouliotis K., Crawford E., Dodkin S., Cue S. Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions. Res Vet Sci 2008, 85:166-170.
24. Piccione G., Casella S., Giannetto C., Giudice E. Effect of storage conditions on prothrombin time, activated partial thromboplastin time and fibrinogen concentration on canine plasma samples. J Vet Sci 2010, 11:121-124.
25. Sié P., Steib A. Central laboratory and point of care assessment of perioperative hemostasis. Can J Anaesth 2006, 53:S12-S20.
26. Taylor L.J. Laboratory management of the bleeding patient. Clin Lab Sci 2003, 16:111-114.
27. Brooks M., Catalfamo J. Buccal mucosa bleeding time is prolonged in canine models of primary hemostatic disorders. Thromb Haemost 1993, 70:777-780.
28. Harker L.A., Slichter S.J. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972, 287:155-159.
29. Jergens A.E., Turrentine M.A., Kraus K.H., Johnson G.S. Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand's disease. Am J Vet Res 1987, 48:1337-1342.
30. Forsythe L.T., Willis S.E. Evaluating oral mucosa bleeding times in healthy dogs using a spring-loaded device. Can Vet J 1989, 30:344-345.
31. Chang Y.W., Liao C.H., Day Y.J. Platelet function analyzer (PFA-100) offers higher sensitivity and specificity than thromboelastography (TEG) in detection of platelet dysfunction. Acta Anaesthesiol Taiwan 2009, 47:110-117.
32. Dyszkiewicz-Korpanty A.M., Frenkel E.P., Sarode R. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 2005, 11:25-35.
33. Marschner C.B., Kristensen A.T., Spodsberg E.H., et al. Evaluation of platelet aggregometry in dogs using the Multiplate platelet analyzer: impact of anticoagulant choice and assay duration. J Vet Emerg Crit Care 2012, 22:107-115.
34. Favaloro E.J. Clinical utility of the PFA-100. Semin Thromb Hemost 2008, 34:709-733.
35. Mischke R., Keidel A. Influence of platelet count, acetylsalicylic acid, von Willebrand's disease, coagulopathies, and haematocrit on results obtained using a platelet function analyser in dogs. Vet J 2003, 165:43-52.
36. Callan M.B., Giger U. Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs. Am J Vet Res 2001, 62:652-658.
37. Callan M.B., Giger U., Catalfamo J.L. Effect of desmopressin on von Willebrand factor multimers in Doberman Pinschers with type 1 von Willebrand disease. Am J Vet Res 2005, 66:861-867.
38. Burgess H.J., Woods J.P., Abrams-Ogg A.C., Wood R.D. Evaluation of laboratory methods to improve characterization of dogs with von Willebrand disease. Can J Vet Res 2009, 73:252-259.
39. Patzke J., Schneppenheim R. Laboratory diagnosis of von Willebrand disease. Hamostaseologie 2010, 30:203-206.
40. Yaxley P.E., Beal M.W., Jutkowitz L.A., et al. Comparative stability of canine and feline hemostatic proteins in freeze-thaw-cycled fresh frozen plasma. J Vet Emerg Crit Care (San Antonio) 2010, 20:472-478.
41. Triplett D.A. Coagulation and bleeding disorders: review and update. Clin Chem 2000, 46:1260-1269.
42. Palmer R.L. Laboratory diagnosis of bleeding disorders. Basic screening tests. Postgrad Med 1984, 76:137-138.
43. Angelos M.G., Hamilton G.C. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time. Emerg Med Clin North Am 1986, 4:95-113.
44. Pachtinger G.E., Otto C.M., Syring R.S., et al. Incidence of prolonged prothrombin time in dogs following gastrointestinal decontamination for acute anticoagulant rodenticide ingestion. J Vet Emerg Crit Care 2008, 18:285-291.
45. Mount M.E., Kim B.U., Kass P.H. Use of a test for proteins induced by vitamin K absence or antagonism in diagnosis of anticoagulant poisoning in dogs: 325 cases (1987-1997). J Am Vet Med Assoc 2003, 222:194-198.
46. Rozanski E.A., Drobatz K.J., Hughes D., et al. Thrombotest (PIVKA) test results in 25 dogs with acquired and hereditary coagulopathies. J Vet Emerg Crit Care 1999, 9:73-78.
47. Vet J., Center S.A., Warner K., Corbett J., et al. Proteins invoked by vitamin K absence and clotting times in clinically ill cats. Intern Med 2000, 14:292-297.
48. Dudek M.M., Kent N., Gustafsson K.M., Lindahl T.L., Killard A.J. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time. Anal Chem 2011, 83:319-328.
49. Green R.A., White F. Feline factor XII (Hageman) deficiency. Am J Vet Res 1977, 38:893-895.
50. See A.M., Swindells K.L., Sharman M.J., et al. Activated coagulation times in normal cats and dogs using MAX-ACT tubes. Aust Vet J 2009, 87:292-295.
51. Nichols T.C., Raymer R.A., Franck H.W., et al. Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B. Haemophilia 2010, 16(suppl 3):19-23.
52. Ameri M., Schnaars H.A., Sibley J.R., Honor D.J. Determination of plasma fibrinogen concentrations in beagle dogs, cynomolgus monkeys, New Zealand white rabbits, and Sprague-Dawley rats by using Clauss and prothrombin-time-derived assays. J Am Assoc Lab Anim Sci 2011, 50:864-867.
53. Mosesson M.W. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 1992, 29:177-188.
54. Doolittle R.F. Fibrinogen and fibrin. Sci Am 1981, 245:126-135.
55. Stokol T., Brooks M., Erb H., Mauldin G.E. Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs. J Vet Intern Med 1999, 13:478-484.
56. Boisvert A.M., Swenson C.L., Haines C.J. Serum and plasma latex agglutination tests for detection of fibrin(ogen) degradation products in clinically ill dogs. Vet Clin Pathol 2001, 30:133-136.
57. Stokol T. Plasma D-dimer for the diagnosis of thromboembolic disorders in dogs. Vet Clin North Am Small Anim Pract 2003, 33:1419-1435.
58. Griffin A., Callan M.B., Shofer F.S., Giger U. Evaluation of a canine D-dimer point-of-care test kit for use in samples obtained from dogs with disseminated intravascular coagulation, thromboembolic disease, and hemorrhage. Am J Vet Res 2003, 64:1562-1569.
59. Nelson O.L., Andreasen C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med 2003, 17:830-834.
60. McMichael M.A., Smith S.A. Viscoelastic coagulation testing: technology, applications, and limitations. Vet Clin Pathol 2011, 40:140-153.
61. Kaufmann C.R., Dwyer K.M., Crews J.D., Dols S.J., Trask A.L. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997, 42:716-720.
62. Wagg C.R., Boysen S.R., Bédard C. Thrombelastography in dogs admitted to an intensive care unit. Vet Clin Pathol 2009, 38(4):453-461.
63. Wiinberg B., Jensen A.L., Rozanski E., et al. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 2009, 179:121-129.
64. Wiinberg B., Jensen A.L., Johansson P.I., Rozanski E., Tranholm M., Kristensen A.T. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008, 22:357-365.
65. Otto C.M., Rieser T.M., Brooks M.B., Russell M.W. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000, 217:1500-1504.
66. Kristensen A.T., Wiinberg B., Jessen L.R., Andreasen E., Jensen A.L. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008, 22:140-147.
67. Sinnott V.B., Otto C.M. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care (San Antonio) 2009, 19:484-488.
68. Smith S.A., McMichael M., Gilor S., et al. Results of thromboelastometry on canine whole blood correlate with hematocrit, platelet concentration, and plasma coagulation factors. Am J Vet Res 2009, 73(6):789-798.
69. Smith S.A., McMichael M., Galligan A., et al. Effect of in vivo reduction in red cell mass on results of canine whole blood thromboelastometry. J Thromb Haemost 2009, [abstract], 7-TH-255.
70. Di Cera E. Thrombin as procoagulant and anticoagulant. J Thromb Haemost 2007, 5(suppl 1):196-202.
71. Hemker H.C., Giesen P., AlDieri R., et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002, 32:249-253.
72. Regnault V., Béguin S., Lecompte T. Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability. Pathophysiol Haemost Thromb 2003, 33:23-29.
73. Hemker H.C., Al Dieri R., De Smedt E., Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006, 96:553-561.
74. Hemker H.C., Giesen P., Al Dieri R., et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003, 33:4-15.
75. Hemker H.C., Giesen P.L., Ramjee M., Wagenvoord R., Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000, 83:589-591.
76. Pelzer H., Schwarz A., Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988, 59:101-106.
77. Boisclair M.D., Lane D.A., Wilde J.T., Ireland H., Preston F.E., Ofosu F.A. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Br J Haematol 1990, 74:471-479.
78. Jacoby R.C., Owings J.T., Ortega T., Gosselin R., Feldman E.C. Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7. Arch Surg 2001, 136:1003-1006.
79. Maruyama H., Watari T., Miura T., et al. Plasma thrombin-antithrombin complex concentrations in dogs with malignant tumours. Vet Rec 2005, 156:839-840.